Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cells

Journal of Cellular Physiology

Volumn 175, Issue 2, 1998, Pages 141-148

  Guo, Yan Shi ^a   Jin, Gui Fang ^a   Houston, Clifford W ^a   Thompson, James C ^a   Townsend Jr , Courtney M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DACTINOMYCIN; DOXORUBICIN; GLYCOPROTEIN P; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MEVINOLIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; COLON CANCER; CONTROLLED STUDY; CYTOCHEMISTRY; IN VITRO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C H RAS; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL SURVIVAL; COLONIC NEOPLASMS; DACTINOMYCIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; GENES, MDR; GENES, RAS; INSULIN-LIKE GROWTH FACTOR I; LOVASTATIN; MICE; MITOCHONDRIA; P-GLYCOPROTEIN; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031935621     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O     Document Type: Article

References (43)

1. Blakesley, V.A., Kalebic, T., Helman, L.J., Stannard, B., Faria, T.N., Roberts, C.T., Jr., and Le Roith, D. (1996) Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Endocrinology, 137:410-417.
2. Bradley, G., and Ling, V. (1994) P-glycoprotein, multidrug resistance tumor progression. Cancer Metastasis Rev., 13:223-233.
3. Brawn, K., and Fridovich, I. (1981) DNA strand scission by enzymically generated oxygen radicals. Arch. Biochem. Biophys., 206:414-419.
4. Burt, R.K., Garfield, S., Johnson, K., and Thorgeirsson, S.S. (1988) Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis, 9:2329-2332.
5. Chin, K.-V., Ueda, K., Pastan, I., and Gottesman, M.M. (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science, 255:459-462.
6. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
7. Combates, N.J., Rzepka, R.W., Chen, Y.-N.P., and Cohen, D. (1994) NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J. Biol. Chem., 269:29715-29719.
8. H genes mutated at codon 61. Cell, 44:167-176.
9. Freeman, B.A., and Crapo, J.D. (1982) Biology of disease. Free radicals and tissue injury. Lab. Invest., 47:412-426.
10. Geier, A., Hemi, R., Haimson, M., and Beery, R. (1993) Epidermal growth factor and insulin-like growth factor-1 preserve cell viability in the absence of protein synthesis. In Vitro Cell Dev. Biol., 29A:231-234.
11. Geier, A., Beery, R., Haimsohn, M., and Karasik, A. (1995) Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: Involvement of growth factors in drug resistance. Cancer Invest., 13:480-486.
12. Guo, Y.-S., Narayan, S., Yallampalli, C., and Singh, P. (1992) Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology, 102:1101-1108.
13. Guo, Y.-S., Beauchamp, R.D., Jin, G.-F., Townsend, C.M., Jr., and Thompson, J.C. (1993a) Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells. Gastroenterology, 104:1595-1604.
14. Guo, Y.-S., Jin, G.-F., Houston, C.W., Townsend, C.M., Jr., and Thompson, J.C. (1993b) Insulin-like growth factors stimulate chemotactic migration of human colon adenocarcinoma (COLO205) cells in vitro. Gastroenterology, 104:A407.
15. Guo, Y.-S., Jin, G.-F., Townsend, C.M., Jr., Zhang, T., Sheng, H.-M., Beauchamp, R.D., and Thompson, J.C. (1995) Insulin-like growth factor-II expression in carcinoma in colon cell lines: Implications for autocrine actions. J. Am. Coll. Surg., 181:145-154.
16. Guo, Y.-S., Thompson, J.C., and Townsend, C.M., Jr. (1998) Insulin-like growth factor and their binding proteins in the gastrointestinal system. In: Endocrinology of the Gastrointestinal System. G.H. Greeley, Jr., ed. Humana Press, Inc., Totowa, NJ (in press).
17. Hayes, J.D., and Wolf, C.R. (1994) Molecular mechanisms of drug resistance. Biochem. J., 272:281-295.
18. Hirose, K., Longo, D.L., Oppenheim, J.J., and Matsushima, K. (1993) Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J., 7:361-368.
19. Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. (1996) Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene, 12:1231-1238.
20. Jones, J.I., and Clemmons, D.R. (1996) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16:3-34.
21. Jones, K.D., Couldwell, W.T., Hinton, D.R., Su, Y., He, S., Anker, L., and Law, R.E. (1994) Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun., 205:1681-1687.
22. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T., Jr. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16:143-163.
23. Louis, J.-C., Magal, E., Takayama, S., and Varon, S. (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science, 259:689-692.
24. Lu, K., Levine, R.A., and Campisi, J. (1989) c-ras-Ha gene expression is regulated by insulin or insulinlike growth factor and by epidermal growth factor in murine fibroblasts. Mol. Cell. Biol., 9:3411-3417.
25. Miller, A.C., and Dvorit, S. (1995) Tumor resistance to oxidative stress: Association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21 ras isoprenylation. Int. J. Cancer, 60:249-254.
26. Miltenberger, R.J., Farnham, P.J., Smith, D.E., Stommel, J.M., and Cornwall, M.M. (1995) v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. Cell Growth Differ., 6:549-556.
27. Moody, C.S., and Hassan, H.M. (1982) Mutagenicity of oxygen free radicals. Proc. Natl. Acad. Sci. USA, 79:2855-2859.
28. Neff, N.T., Prevette, D., Houenou, L.J., Lewis, M.E., Glicksman, M.A., Yin, Q.W., and Oppenheim, R.W. (1993) Insulin-like growth factors: Putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol., 24:1578-1588.
29. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G.I., Baserga, R., and Blättler, W.A. (1997) Identification of domains of the insulin-like growth factor-I receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17:427-435.
30. Pantazis, P., DeJesus, A., Early, J., Rodriguez, R., Chatterjee, D., Han, Z., Wyche, J., and Biovanella, B. (1995) Development of human leukemia U-937 cell sublines resistant to doxorubicin: Induction of differentiation and altered sensitivities to topoisomerase-directed drugs. Anticancer Res., 15:1873-1882.
31. Parker, S.L., Tong, T., Bolden, S., and Wingo, P.A. (1996) Cancer statistics, 1996. CA Cancer J. Clin., 46:5-27.
32. Pérez-Sala, D., and Mollinedo, F. (1994) Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem. Biophys. Res. Commun., 199:1209-1215.
33. Remacle-Bonnett, M.M., Culouscou, J.M., Garrouste, F.L., Rabenanadrasana, C., Marvaldi, J.L., and Pommier, G.J. (1992) Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line. J. Clin. Endocrinol. Metab., 75:609-616.
34. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H.L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55(11):2463-2469.
35. Rodriguez-Tarduchy, G., Collins, M.K., Garcia, I., and López-Rivas, A. (1992) Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol., 149:535-540.
36. Sell, C., Baserga, R., and Rubin, R. (1995) Insulin-like growth factor I (IGF-I) and IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55:303-306.
37. Sumi, S., Beauchamp, R.D., Townsend, C.M., Jr., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., and Thompson, J.C. (1992) Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology, 103:982-989.
38. Sumi, S., Beauchamp, R.D., Townsend, C.M., Jr., Pour, P.M., Ishizuka, J., and Thompson, J.C. (1994) Lovastatin inhibits pancreatic cancer growth regardless of RAS mutation. Pancreas, 9:657-661.
39. Svingen, B.A., O'Neal, F.O., and Aust, S.D. (1978) The role of superoxide and singlet oxygen in lipid peroxidation. Photochem. Photobiol., 25:803-809.
40. Teeter, L.D., Becker, F.F., Chisari, F.V., Li, D., and Kuo, M.T. (1990) Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol. Cell. Biol., 10:5728-5735.
41. Winsett, O.E., Townsend, C.M., Jr., Glass, E.J., and Thompson, J.C. (1986) Gastrin stimulates growth of colon cancer. Surgery, 99:302-307.
42. Wyllie, A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284: 555-556.
43. Zarrilli, R., Pignanta, S., Romano, M., Gravina, A., Sasola, S., and Bruni, C.B. (1994) Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differ., 5:1085-1091.